Behrens, H. M., Six, A., Walker, D. and Kleanthous, C. (2017) The therapeutic potential of bacteriocins as protein antibiotics. Emerging Topics in Life Sciences, 1(1), pp. 65-74. (doi: 10.1042/ETLS20160016)
|
Text
138794.pdf - Published Version Available under License Creative Commons Attribution. 581kB |
Abstract
The growing incidence of antibiotic-resistant Gram-negative bacterial infections poses a serious threat to public health. Molecules that have yet to be exploited as antibiotics are potent protein toxins called bacteriocins that are produced by Gram-negative bacteria during competition for ecological niches. This review discusses the state of the art regarding the use for therapeutic purposes of two types of Gram-negative bacteriocins: colicin-like bacteriocins (CLBs) and tailocins. In addition to in vitro data, the potency of eight identified CLBs or tailocins has been demonstrated in diverse animal models of infection with no adverse effects for the host. Although the characteristics of bacteriocins will need further study, results obtained thus far regarding their in vivo potency, immunogenicity and low levels of resistance are encouraging. This leads the way for the development of novel treatments using bacteriocins as protein antibiotics.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Walker, Professor Daniel and Six, Dr Anne |
Authors: | Behrens, H. M., Six, A., Walker, D., and Kleanthous, C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Emerging Topics in Life Sciences |
Publisher: | Portland Press |
ISSN: | 2397-8554 |
ISSN (Online): | 2397-8562 |
Published Online: | 21 April 2017 |
Copyright Holders: | Copyright © 2017 The Authors |
First Published: | First published in Emerging Topics in Life Sciences 1(1): 65-74 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record